Shuo Qie

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Reactive Oxygen Species

Top Venues

Cell death & disease

Research square

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Cell death & disease 15 (8) (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Research square (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Research square (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Cell death & disease 15 (8) (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Cell death & disease 15 (8) (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Cell death & disease 15 (8) (2024)
Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang
Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Research square (2024)
Meng Zhao, Chen Huang, Lexin Yang, Boyu Pan, Shuting Yang, Jiao Chang, Yu Jin, Gang Zhao, Dongsheng Yue, Shuo Qie, Li Ren
SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma. Cell death & disease 14 (10) (2023)
Yaqi Liu, Haijuan Xiong, Chenhui Yan, Yalei Wang, Wenfeng Cao, Shuo Qie
Bioinformatic Analysis of The Prognostic Value of A Panel of Six Amino Acid Transporters in Human Cancers. Cell journal 25 (9) (2023)
Shuo Qie
The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives. Cancers 14 (9) (2022)
Shuo Qie, Nianli Sang
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Bartosz Mucha, Shuo Qie, Sagar Bajpai, Vincenzo Tarallo, J Nathaniel Diehl, Frank Tedeschi, Gao Zhou, Zhaofeng Gao, Samuel P Flashner, Andres J Klein-Szanto, Hanina Hibshoosh, Shimonosono Masataka, Olga S Chajewski, Ireneusz Majsterek, Dariusz Pytel, Maria Hatzoglou, Channing J Der, Hiroshi Nakagawa, Adam J Bass, Kwok-Kin Wong, Serge Y Fuchs, Anil K Rustgi, Eckhard Jankowsky, J Alan Diehl
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation. Nature communications 13 (1) (2022)
Akihiro Yoshida, Jaewoo Choi, Hong Ri Jin, Yan Li, Sagar Bajpai, Shuo Qie, J Alan Diehl
Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3. Oncogene 40 (2) (2020)
Shuo Qie, J Alan Diehl
Glutamine addiction: an Achilles heel in esophageal cancers with dysregulation of CDK4/6. Molecular & cellular oncology 6 (4) (2019)
Akihiro Yoshida, Yiwen Bu, Shuo Qie, John Wrangle, E Ramsay Camp, Edward S Hazard, Gary Hardiman, Renée de Leeuw, Beatrice Knudsen, J Alan Diehl
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Science advances 5 (9) (2019)